Viewing nowColostatin 20 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

MFDS item code 201400124 · Approved 2014.01.13 · Insurance code 648507110
Improves dyslipidemia, inhibits the progression of atherosclerosis, and prevents cardiovascular disease
This medication is used in patients with primary hypercholesterolemia and mixed dyslipidemia when dietary management and exercise alone are insufficient. It is also prescribed as an adjunct to diet and other lipid-lowering therapies for patients with homozygous familial hypercholesterolemia. It lowers total cholesterol and LDL cholesterol levels, delaying the progression of atherosclerosis. It is also used as an adjunct to diet in pediatric patients aged 10 to 17 years with heterozygous familial hypercholesterolemia. It is also used in patients with primary dysbetalipoproteinemia and has a risk reduction effect for cardiovascular diseases, helping to reduce the risk of stroke, myocardial infarction, and percutaneous coronary intervention. Overall, this medication is effective for cholesterol management and reduction of cardiovascular disease risk.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of the day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient response, and may be increased to a maximum of 20 milligrams daily. 3. Elderly patients: Dose adjustment is not required. 4. Patients with renal impairment: Dose adjustment is not required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution is required when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or lower, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients.
Ages 10–17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on administration of doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy in children have not been established.
This medication should not be used in certain patients. For example, it should not be administered to patients who have an allergy to any component of this medication, those with active liver disease, patients with muscle disorders, patients with significantly impaired kidney function, and women who are pregnant or breastfeeding. Additionally, high doses are prohibited in patients at high risk of muscle disorders. Since this medication contains lactose, it should not be used in patients with lactose intolerance. When using this medication, liver function and muscle status should be monitored periodically. Patients who consume large amounts of alcohol or have a history of liver disease need to be particularly cautious. If symptoms like muscle pain, weakness, or cramps occur, consult a physician immediately. This medication may interact with other drugs, so inform your physician of any other medications you are taking. In particular, the risk of muscle damage may increase when combined with certain antiviral drugs, immunosuppressants, or fibrate derivatives. Women of childbearing potential should use adequate contraception while taking this medication, and should discontinue it immediately if they become pregnant. It is also safest for breastfeeding women not to take this medication. In cases of overdose, there is no specific antidote, so seek medical attention immediately for appropriate treatment. This medication can rarely cause serious side effects such as severe skin reactions, liver damage, kidney issues, and muscle damage, so report any unusual symptoms to medical personnel immediately. Dizziness may occur while driving or operating machinery, so caution is advised. The blood concentration of this medication may be higher in Asians, so dosage adjustments may be necessary. Monitoring growth and development is required when administering this medication to children and adolescents.
Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ophthalmoplegia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal hepatic failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, fatigue, numbness, abnormal sensation, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it must be stored in a tightly closed container. It is important to maintain the storage temperature between 1 degrees Celsius and 30 degrees Celsius. Proper storage will ensure the safety and efficacy of the medication.
Pink round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.